We are live on
!
Find out more
AC
Amici Capital Portfolio holdings
AUM
$257M
1-Year Est. Return
4.88%
This Fund
S&P 500
This Quarter
Est. Return
+0.33%
1 Year Est. Return
+4.88%
3 Year Est. Return
+28.64%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.74B
AUM Growth
–
Cap. Flow
+$2.75B
Cap. Flow
% of AUM
100.32%
Top 10 Holdings %
Top 10 Hldgs %
35.65%
Holding
136
New
133
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$144M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$111M |
| 3 |
Assured Guaranty
AGO
|
+$109M |
| 4 |
Sanofi
SNY
|
+$103M |
| 5 |
NOV
NOV
|
+$98.5M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.69% |
| 2 | Healthcare | 17.58% |
| 3 | Technology | 12.03% |
| 4 | Communication Services | 7.74% |
| 5 | Consumer Discretionary | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALU
126
DELISTED
Alcatel-Lucent
ALU
| $167K | 0.01% |
+95,680
| New | +$143K |
|
|
VVUS
127
DELISTED
Vivus Inc
VVUS
| $126K | ﹤0.01% |
+1,000
| New | +$129K |
|
|
OREX
128
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $117K | ﹤0.01% |
+2,000
| New | +$123K |
|
|
SPPI
129
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $112K | ﹤0.01% |
+15,000
| New | +$115K |
|
130
Plus Therapeutics
PSTV
$26.6M
| – | – |
0
| – | – |
|
|
MAKO
131
DELISTED
MAKO SURGICAL CORP COM
MAKO
| $60K | ﹤0.01% |
+5,000
| New | +$56.8K |
|
132
SIGA Technologies
SIGA
$235M
| $57K | ﹤0.01% |
+20,000
| New | +$67.1K |
|
|
FES
133
DELISTED
Forbes Energy Services Ltd
FES
| $57K | ﹤0.01% |
+14,233
| New | +$51.4K |
|
|
CS
134
DELISTED
Credit Suisse Group
CS
| $46K | ﹤0.01% |
+1,730
| New | +$48.6K |
|
Similar funds
GFG
CAM
SCMC
AS
BREA
BGE
JIAI
SIG
Amici Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Amici Capital, which disclosed 136 positions worth $2.74B. Its ten largest holdings account for 36% of the portfolio.
Its largest position is BioMarin Pharmaceuticals: 2,306,354 shares worth $129M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, followed by Healthcare and Technology.
- Amici Capital's largest Q2 2013 buy was BioMarin Pharmaceuticals: 2,306,354 shares worth $129M.
- Amici Capital's ten largest holdings make up 36% of its $2.74B portfolio in Q2 2013.
- Amici Capital disclosed 136 positions in Q2 2013, its first 13F filing on record.
Based on Amici Capital's 13F filing for Q2 2013, filed 14 Aug 2013.